{"member_organisations": "https://www.medtech-pharma.com/home/", "identification_number": "234427831877-10", "fields_of_interest": "General and Institutional Affairs, Trade, Competition, Consumers, International co-operation and development, Business and Industry, Single market, Public Health, Digital economy and society, Communication, Fraud prevention", "head_office_address": "Medtech & Pharma Platform c/o SFL Regulatory Affairs & Scientific Communication GmbH Margarethenstrasse 47", "full_time_equivalent_fte": "0,75", "person_with_legal_responsibility": "Shayesteh F\u00fcrst-Ladani", "industry_forums": "", "grants": "", "inter_groups": "", "eu_initiatives": "The Medtech & Pharma Platform Association was founded in 2017 and started its activities in 2018. \n \nThe Medtech & Pharma Platform monitors all EU legislative, policy and regulatory developments relating to combined products.  \n \nSpecifically the Medtech & Pharm Platform follows: \n \n\u2022    Medical Device Regulation EU 2017/745 and it implementing and delegated acts as well as any related guidance document \n \n\u2022    In vitro Diagnostic Regulation  EU 2017/746 \n \n\u2022    Medicinal Product Directive EU 2001/83 \n \n\u2022    Proposal for a Regulation on Health Technology  \nAssessment \n \n\u2022    General Data Protection Regulation EU 2016/679 \n \n\u2022    Clinical Trials Regulation EU 536/2014 \n \n\u2022    Policy initiatives, projects, events and publications from DG SANTE, DG GROW, DG CONNECT, DG RESEARCH  \n \n\u2022    Horizon 2020 / Horizon Europe", "level_of_interest": "European", "organisation_name": "Medtech & Pharma Platform (MPP)", "belgium_office_post_code": "", "number_of_persons_involved": "2", "person_in_charge_of_eu_relations": "Shayesteh F\u00fcrst-Ladani", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "subsection": "Trade and business associations", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "25/06/2018", "estimate_of_costs_absolute_amount": "", "website_address": "https://www.medtech-pharma.com/home/", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Basel", "membership": "n.a.", "head_office_post_code": "4053", "position": "MPP President", "financial_year_start_date": "01/02/2017", "head_office_country": "Switzerland", "number_of_ep_accredited_persons": "", "relevant_communication": "", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "50000-99999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "association", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "The Medtech & Pharma Platform is an industry association using the synergies between medtech and pharmaceutical companies by establishing a forum to exchange knowledge and collaborate in technology and regulatory areas, as well as to promote product development and innovation.  \n \nFuture innovative healthcare solutions increasingly rely on combined products from pharma and medtech companies. Collaboration between both industries is therefore key to future innovations.  \n \nThe association\u2019s goals are  \n \n\u2022 Establish new industry collaboration models to ensure and accelerate market access for safe and innovative treatment options in the field of combined products. \n \n\u2022 Manage the interface between industry, policy makers, regulators and notified bodies and foster an open and transparent dialogue. \n \n\u2022 Provide a platform for joint work on a balanced and proportionate regulatory and political framework for combined products that \n \n  o facilitates innovation for the European market, it\u2019s industries and citizens \n \n  o strengthens public health through improved patients\u2019 access to innovative products \n \n  o reduces time to market for drugs, devices and combinations thereof \n \n o  promotes free trade and IP principles \n \nMedtech & Pharm Platform acts with a global mindset but initially focusses on European policy developments.", "belgium_office_city": "", "head_office_phone": "(+41)61 366 71 64"}